Related Experiment Video

Updated: Jul 6, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Immunodeficiencies: injecting some safety into SCID gene therapy?

F Candotti, C Roifman, J M Puck

    Gene Therapy
    |March 26, 2008
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
    03:40

    Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

    Published on: December 8, 2023

    Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA
    11:58

    Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA

    Published on: June 25, 2014

    Related Experiment Videos

    Last Updated: Jul 6, 2026

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
    07:10

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

    Published on: January 7, 2019

    Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
    03:40

    Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

    Published on: December 8, 2023

    Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA
    11:58

    Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA

    Published on: June 25, 2014

    Related Concept Videos

    Immunodeficiency Diseases01:25

    Immunodeficiency Diseases

    Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
    There are three main causes of immunodeficiency disorders...
    Gene Therapy00:59

    Gene Therapy

    Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

    Articles linked to this work by shared authors, journal, and citation graph.

    Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT.

    Blood·2022

    The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors.

    Gene therapy·2016

    Activated STING in a vascular and pulmonary syndrome.

    The New England journal of medicine·2014

    Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency.

    Clinical immunology (Orlando, Fla.)·2011

    Somatic mosaicism caused by monoallelic reversion of a mutation in T cells of a patient with ADA-SCID and the effects of enzyme replacement therapy on the revertant phenotype.

    Scandinavian journal of immunology·2011

    Novel intraoral phenotypes in hyperimmunoglobulin-E syndrome.

    Oral diseases·2008

    An engineered helper plasmid generates differential E4orf6 and L4-22/33K gene expression increasing AAV vector production.

    Gene therapy·2026

    A gene therapy approach to prevent dilated intercellular space, a hallmark of gastroesophageal reflux disease.

    Gene therapy·2026

    Precision correction of the GJB2 c.235delC mutation by prime editing in vitro.

    Gene therapy·2026

    Bone- and muscle-targeted adeno-associated viral vectors enable tissue-selective vitamin D receptor knockdown in mice.

    Gene therapy·2026

    SACF and GILA for in vitro transformation assessment of CRISPR/Cas9-edited cell therapy candidates: a multi-site study.

    Gene therapy·2026

    rAAV production cost analysis: Indication-specific cost per dose and reduction strategies.

    Gene therapy·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us